DJ Amgen Inc. Stock Outperforms Competitors Despite Losses On The Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Amgen Inc. $(AMGN)$ shed 1.44% to $355.25 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.38% to 7,543.59 and the Dow Jones Industrial Average rising 0.02% to 52,508.27.
This was the stock's fifth consecutive day of losses.
Amgen Inc. closed 9.21% short of its 52-week high of $391.29, which the company achieved on March 2nd.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ fell 1.52% to $253.85, Pfizer Inc. $(PFE)$ fell 0.94% to $24.25, and AbbVie Inc. $(ABBV)$ fell 1.30% to $244.78.
Trading volume (1.5 M) remained 1.3 million below its 50-day average volume of 2.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 14, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
July 14, 2026 16:34 ET (20:34 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments